These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2744881)

  • 1. Plasma dilution during transdermal clonidine antihypertensive monotherapy.
    Zawada ET; Jensen RA; Williams L; Zeigler DW; Kauker ML
    Int J Artif Organs; 1989 Mar; 12(3):200-3. PubMed ID: 2744881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of transdermal clonidine in chronic hemodialysis patients.
    Rosansky SJ; Johnson KL; McConnell J
    Clin Nephrol; 1993 Jan; 39(1):32-6. PubMed ID: 8428405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal clonidine compared with hydrochlorothiazide as monotherapy in elderly hypertensive males.
    Schmidt GR; Schuna AA; Goodfriend TL
    J Clin Pharmacol; 1989 Feb; 29(2):133-9. PubMed ID: 2715369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One year efficacy and tolerability of clonidine administered by the transdermal route in patients with mild to moderate essential hypertension--a multicentre open label study. The Antihypertensive Patch Italian Study (APIS) Investigators.
    Clin Auton Res; 1993 Dec; 3(6):379-83. PubMed ID: 8193525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indapamide regresses, but transdermal clonidine does not regress, left ventricular hypertrophy in hypertensive diabetic patients.
    Tan SA; Berk LS; Tan LG
    Am J Cardiol; 1996 Feb; 77(6):20B-22B. PubMed ID: 8848989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of a transdermal delivery system for antihypertensive therapy. Part 2.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):57S-60S. PubMed ID: 1907802
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine.
    Zawaideh MA; Duncan B; Joseph MW; Dixit MP
    Pediatr Nephrol; 2001 Jan; 16(1):85-6. PubMed ID: 11198612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with rate-controlled delivery of antihypertensive therapy by a transdermal system.
    Weber MA; Drayer JI
    Am Heart J; 1984 Jul; 108(1):231-6. PubMed ID: 6375331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values.
    Schaller MD; Nussberger J; Waeber B; Porchet M; Brunner HR
    JAMA; 1985 Jan; 253(2):233-5. PubMed ID: 3965774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
    Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
    Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal clonidine (Catapres-TTS) monotherapy in the management of mild hypertension in general practice.
    Lewis GR
    N Z Med J; 1987 Nov; 100(836):711-3. PubMed ID: 3330602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Langley MS; Heel RC
    Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebound hypertension during initiation of transdermal clonidine.
    Stewart M; Burris JF
    Drug Intell Clin Pharm; 1988; 22(7-8):573-4. PubMed ID: 3416742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG; Jain AK; Vargas R; Fillingim J
    Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats.
    Ishii R; Furuta M; Hashimoto M; Tagawa T; Naruse T; Hata T
    Arzneimittelforschung; 1998 Aug; 48(8):811-7. PubMed ID: 9748708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.